2025 연구성과 (14 / 151)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
WoS SCOPUS Document Type Document Title Abstract Authors Affiliation ResearcherID (WoS) AuthorsID (SCOPUS) Author Email(s) Journal Name JCR Abbreviation ISSN eISSN Volume Issue WoS Edition WoS Category JCR Year IF JCR (%) FWCI ⓘ FWCI Update Date WoS Citation SCOPUS Citation Keywords (WoS) KeywordsPlus (WoS) Keywords (SCOPUS) KeywordsPlus (SCOPUS) Language Publication Stage Publication Year Publication Date DOI JCR Link DOI Link WOS Link SCOPUS Link
○ Meeting Abstract ⓘ Correlation of Impulse Oscillometry With Computed Tomography Imaging Metrics in Asthmatic Patients ⓘ ⓘ Kim, G.; Lee, H.; So, S.; Kim, S.; Chae, K.; Yoo, J.; Kim, S.; Choi, S. ⓘ Kyungpook Natl Univ, Sch Mech Engn IEDT, Daegu, South Korea; Hanyang Univ Hosp, Dept Internal Med, Seoul, South Korea; Hanyang Univ Hosp, Seoul, South Korea; Kyungpook Nant Univ Hosp, Dept Internal Med, Daegu, South Korea; Jeonbuk Natl Univ Hosp, Dept Radiol, Jeonju, South Korea; Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Daegu, South Korea ⓘ ⓘ ⓘ ⓘ AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE ⓘ AM J RESP CRIT CARE ⓘ 1073-449X 1535-4970 211 SCIE CRITICAL CARE MEDICINE;RESPIRATORY SYSTEM ⓘ 2024 19.4 3.2 ⓘ 0 ⓘ ⓘ ⓘ ⓘ English 2025 2025-05-01 ⓘ 바로가기 바로가기
○ Meeting Abstract ⓘ Differential Airway and Structural Lung Changes in Chronic Obstructive Pulmonary Disease and Preserved Ratio of Impaired Spirometry ⓘ ⓘ Kim, Y.; Moon, J. Y.; Kim, G.; Choi, S.; Joo, H. ⓘ Konkuk Univ, Konkuk Univ Hosp, Sch Med, Seoul, South Korea; Kyungpook Natl Univ, Daegu, South Korea; Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Seoul, South Korea ⓘ ⓘ ⓘ weilin810707@gmail.com; ⓘ AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE ⓘ AM J RESP CRIT CARE ⓘ 1073-449X 1535-4970 211 SCIE CRITICAL CARE MEDICINE;RESPIRATORY SYSTEM ⓘ 2024 19.4 3.2 ⓘ 0 ⓘ ⓘ ⓘ ⓘ English 2025 2025-05-01 ⓘ 바로가기 바로가기
○ ○ Article ⓘ Effect of intensive nutritional support on functional recovery in subacute stroke: A randomized, multicenter, single-blinded trial ⓘ Background: Nutrition in the subacute phase of stroke may be a critical factor in functional recovery and post-stroke mortality. Nevertheless, the issue of intensive nutritional support for people with subacute stroke remains insufficiently explored. Objectives: This study investigated the effects of intensive nutritional support during rehabilitation on functional recovery in the subacute phase of participants with a first-ever stroke. Methods: This randomized, single-blinded, parallel-designed study is part of the Korean Stroke Cohort for Functioning and Rehabilitation, a 10-year long-term follow-up of stroke participants. A total of 91 first-ever stroke participants were recruited from 5 hospitals and randomly allocated to the intensive nutrition (IN) group (n = 43) or the conventional nutrition (CN) group (n = 48). All participants received the same comprehensive inpatient stroke rehabilitation. During the three-week intervention period, the IN group received an additional 500 kcal daily by intravenous nutritional infusion, while both groups received usual nutrition. Functional assessments and nutritional status were evaluated at baseline, post-intervention, and 6 months after stroke onset. Repeated measures ANOVA and post-hoc analyses were used for intention-to-treat analysis. Results: Baseline characteristics were not significantly different between the groups. The dropout rate was significantly higher in the IN group (20 %) than in the CN group (2 %). A repeated measures ANOVA demonstrated significant interactions between time and intervention for the modified Barthel index (P = 0.02, r)2 = 0.05, small) and nutrition risk screening 2002 (P = 0.03, r)2 = 0.03, small), indicating significant improvements in the IN group. The modified Barthel Index, Nutrition Risk Screening 2002, and Functional Ambulation Category demonstrated significantly higher changes in the IN group compared to the CN group between time points. Conclusions: Intensive nutritional support during comprehensive rehabilitation could provide additional functional improvement in subacute stroke participants. However, alternative methods of intensive nutrition should be explored, as intravenous nutritional infusions were not well-tolerated by some participants. Clinical Trial Registry number and website: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04259307. (c) 2025 Published by Elsevier Masson SAS. ⓘ Kim, Dae Hyun; Sohn, Min Kyun; Lee, Jongmin; Kim, Deog Young; Shin, Yong-Il; Oh, Gyung-Jae; Lee, Yang-Soo; Joo, Min Cheol; Lee, So Young; Song, Min-Keun; Han, Junhee; Ahn, Jeonghoon; Lee, Ho Seok; Kim, Young-Taek; Kim, Yun-Hee; Chang, Won Hyuk ⓘ Sungkyunkwan Univ, Heart Vasc Stroke Inst, Ctr Prevent & Rehabil, Dept Phys & Rehabil Med,Samsung Med Ctr,Sch Med, Seoul 06355, South Korea; Chungnam Natl Univ, Coll Med, Dept Rehabil Med, Daejeon 35015, South Korea; Konkuk Univ, Sch Med, Dept Rehabil Med, Seoul 05029, South Korea; Yonsei Univ, Dept & Res Inst Rehabil Med, Coll Med, Seoul 03722, South Korea; Pusan Natl Univ, Yangsan Hosp, Dept Rehabil Med, Yangsan 50612, South Korea; Wonkwang Univ, Sch Med, Dept Prevent Med, Iksan 54538, South Korea; Kyungpook Natl Univ Hosp, Dept Rehabil Med, Daegu 41944, South Korea; Wonkwang Univ, Sch Med, Dept Rehabil Med, Iksan 54538, South Korea; Jeju Natl Univ Hosp, Dept Rehabil Med, Jeju 63241, South Korea; Chonnam Natl Univ, Dept Phys & Rehabil Med, Med Sch, Gwangui 61469, South Korea; Hallym Univ, Dept Stat, Chunchon 24252, South Korea; Ewha Womans Univ, Dept Hlth Convergence, Seoul 03760, South Korea; Chungnam Natl Univ Hosp, Dept Prevent Med, Daejeon 35015, South Korea; Sungkyunkwan Univ, Sch Med, Suwon 16419, South Korea; Sungkyunkwan Univ, Dept Hlth Sci & Technol, Dept Med Device Management & Res, SAIHST, Suwon 16419, South Korea ⓘ kim, deog young/Q-8498-2019; Kim, Young/AEP-2940-2022 ⓘ 57206099341; 7101840459; 57202882113; 55375583000; 55890990500; 7007056685; 57202952463; 56982599700; 57202327370; 55375416600; 57192890252; 8855402200; 57222648792; 57211411051; 57020121600; 35301717900 ⓘ yunkim@skku.edu; wh.chang@samsung.com; ⓘ ANNALS OF PHYSICAL AND REHABILITATION MEDICINE ⓘ ANN PHYS REHABIL MED ⓘ 1877-0657 1877-0665 68 4 SCIE REHABILITATION ⓘ 2024 4.6 3.2 0 2025-05-07 ⓘ 0 0 Functional recovery; Nutritional status; Nutritional support; Stroke; Stroke rehabilitation; Randomized controlled trial ⓘ ISCHEMIC-STROKE; MALNUTRITION; OUTCOMES; OVERWEIGHT; OBESITY; SUPPLEMENTATION; PREVALENCE; FOOD ⓘ Functional recovery; Nutritional status; Nutritional support; Randomized controlled trial; Stroke; Stroke rehabilitation ⓘ Aged; Female; Humans; Male; Middle Aged; Nutritional Status; Nutritional Support; Recovery of Function; Republic of Korea; Single-Blind Method; Stroke; Stroke Rehabilitation; Treatment Outcome; aged; analysis of variance; Article; Barthel index; cerebrovascular accident; controlled study; female; follow up; functional assessment; human; intention to treat analysis; lymphocyte count; major clinical study; male; multicenter study; nutritional status; nutritional support; post hoc analysis; randomized controlled trial; single blind procedure; stroke rehabilitation; cerebrovascular accident; clinical trial; convalescence; middle aged; nutritional status; pathophysiology; procedures; South Korea; stroke rehabilitation; treatment outcome ⓘ English 2025 2025-05 10.1016/j.rehab.2025.101976 ⓘ 바로가기 바로가기 바로가기 바로가기
○ ○ Article ⓘ Experimental investigation of oxy-combustion using plastic waste pyrolysis fuel for CO2 capture technology ⓘ In response to the worsening environmental and energy crises, strategic research on plastic disposal (pyrolysis) and CO2 negative application (oxy-fuel combustion) was carried out. The upgraded plastic pyrolysis oil was used to evaluate the performance of oxy-fuel combustion in a 5-kW scale boiler. Plastic oil middle distillate (diesel-like fraction, C-11-C-22) exhibits similar characteristics to diesel (e.g. HHV: 45.0 MJ/kg, viscosity: 2.70 cSt at 40 degrees C), resulting in a perfect miscibility. The 30 %P-oil (mixed fuel of plastic middle fraction pyrolysis oil for 30 wt% and petroleum diesel for 70 wt%) and pure diesel were applied for the oxy-fuel combustion study, respectively. The boiler efficiency of 30 %P-oil was about 62 %, close to pure diesel combustion (similar to 61 %), higher than air combustion (similar to 58 %) with mixed fuels in our previous study. The maximum boiler internal temperature was observed at 1080-1090 degrees C at 25 %O-2 and 75 %CO2 of inlet gas concentration. Emission analysis showed that both the 30 %P-oil and diesel combustion emitted similar flue gas concentrations of CO (80-120 ppm), SO2 (6-9 ppm) and CO2 (similar to 95 %) at 25 %O-2 condition. On the other hand, 30 %P-oil showed higher NO concentration (61 ppm) than diesel (20 ppm) because of higher presence of the nitrogen content in plastic pyrolysis oil. Finally, highly concentrated CO2 (similar to 95 %) was captured over oxy-fuel combustion, leading to CO2-negative technology. ⓘ Wang, Shuang; Hwang, Sung-Chul; Yuan, Xiangzhou; Nam, Hyungseok ⓘ Kyungpook Natl Univ, Sch Mech Engn, Daegu 41566, South Korea; Kyungpook Natl Univ, IEDT, Daegu 41566, South Korea; Rensselaer Polytech Inst RPI, Civil & Environm Engn, Troy, NY 12180 USA; GET SCR Co Ltd, R&D Ctr, Mryang 50404, South Korea; Southeast Univ, Sch Energy & Environm, Minist Educ, Key Lab Energy Thermal Convers & Control, Nanjing 210096, Peoples R China ⓘ Yuan, Xiangzhou/I-3671-2018 ⓘ 57216215741; 57191483720; 55355428200; 57190418228 ⓘ namhs219@knu.ac.kr; ⓘ ENERGY ⓘ ENERGY ⓘ 0360-5442 1873-6785 325 SCIE ENERGY & FUELS;THERMODYNAMICS ⓘ 2024 9.4 3.2 0 2025-05-07 ⓘ 0 0 Plastic waste; Pyrolysis oil; Oxy-fuel combustion; CO2 capture; Emission analysis ⓘ BIO-OIL; PERFORMANCE; DISTILLATION; EMISSION ⓘ CO<sub>2</sub> capture; Emission analysis; Oxy-fuel combustion; Plastic waste; Pyrolysis oil ⓘ Flue gases; Pyrolysis; Waste incineration; CO2 capture; Diesel combustion; Emission analysis; Experimental investigations; Mixed fuel; Oxy combustions; Oxyfuel combustion; Plastic pyrolysis; Plastics waste; Pyrolysis oil; carbon sequestration; combustion; emission; experimental study; fuel; plastic waste; pyrolysis ⓘ English 2025 2025-06-15 10.1016/j.energy.2025.136116 ⓘ 바로가기 바로가기 바로가기 바로가기
○ Meeting Abstract ⓘ Glomerular Filtration Rate Trajectory in Patients With Interstitial Lung Disease: A Matched Control Study ⓘ ⓘ Kim, K.; Jang, H.; Jeong, J.; Huh, J.; Kim, Y.; Choi, W. ⓘ Incheon St Marys Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Incheon, South Korea; Inha Univ Hosp, Dept Internal Med, Div Pulmonol, Incheon, South Korea; Kyungpook Natl Univ, Dept Stat, Daegu, South Korea; Chung Ang Univ, Gwangmyeong Hosp, Div Pulm Allergy & Crit Care Med, Gwangmyeong, South Korea; Hanyang Univ, Myongji Hosp, Dept Internal Med, Goyang Si, South Korea ⓘ ⓘ ⓘ kyunghoonkim@catholic.ac.kr; ⓘ AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE ⓘ AM J RESP CRIT CARE ⓘ 1073-449X 1535-4970 211 SCIE CRITICAL CARE MEDICINE;RESPIRATORY SYSTEM ⓘ 2024 19.4 3.2 ⓘ 0 ⓘ ⓘ ⓘ ⓘ English 2025 2025-05-01 ⓘ 바로가기 바로가기
○ Meeting Abstract ⓘ Hemoglobin Trajectory in Patients With Interstitial Lung Disease ⓘ ⓘ Choi, W. -I.; Jang, H.; Jeong, J.; Huh, J. -Y.; Kim, K. ⓘ Hanyang Univ, Myongji Hosp, Goyang Si, South Korea; Inha Univ, Inha Univ Hosp, Coll Med, Incheon, South Korea; Kyungpook Natl Univ, Daegu, South Korea; Chung Ang Univ, Gwangmyeong Hosp, Gwangmyeong Si, South Korea; Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Incheon, South Korea ⓘ ⓘ ⓘ ⓘ AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE ⓘ AM J RESP CRIT CARE ⓘ 1073-449X 1535-4970 211 SCIE CRITICAL CARE MEDICINE;RESPIRATORY SYSTEM ⓘ 2024 19.4 3.2 ⓘ 0 ⓘ ⓘ ⓘ ⓘ English 2025 2025-05-01 ⓘ 바로가기 바로가기
○ ○ Article ⓘ Impact of lightweighting and driving conditions on electric vehicle energy consumption: In-depth analysis using real-world testing and simulation ⓘ Electric vehicles have limited driving range due to the restricted battery capacity, making it essential to enhance energy efficiency. Traditionally, energy consumption can be reduced by lightweighting or moderating acceleration and deceleration. However, unlike conventional vehicles that use friction braking, electric vehicles recover energy through regenerative braking. Therefore, it is important to understand how factors like vehicle weight, acceleration, and road gradient affect energy consumption in electric vehicles. This study conducted real-world driving tests by adjusting vehicle weight to analyze the impact of lightweighting on energy consumption. Simulations were also used to analyze various acceleration and road gradients, enabling a quantitative assessment of energy consumption at both wheel and battery levels. Results showed that a 15 % increase in vehicle weight caused a 4-9 % rise in wheel energy consumption. Although this is smaller than what is typically observed in conventional vehicles, it is still significant. Changes in acceleration and road gradient had minimal effects on wheel energy consumption but significantly impacted battery energy use. Doubling the acceleration in the UDDS and WLTP cycles reduced energy efficiency by 20.8 % and 12.7 %, respectively. This study provides key insights for improving electric vehicle energy efficiency and offers valuable guidance for advancing electric vehicle technology. ⓘ Choi, Mingi; Cha, Junepyo; Song, Jingeun ⓘ Hanyang Cyber Univ, Sch Mech & Automot Engn, Seoul 04763, South Korea; Korea Natl Univ Transportat, Dept Automot Engn, Chungju 27469, Choongcheongboo, South Korea; Kyungpook Natl Univ, Sch Automot Engn, 2559 Gyeongsang Daero, Sangju 37224, Gyeongbuk, South Korea; Kyungpook Natl Univ, Convergence Res Ctr Mech & Chem Engn CRCMCE, 2559 Gyeongsang Daero, Sangju 37224, Gyeongbuk, South Korea ⓘ Song, Jingeun/MTG-2604-2025 ⓘ 55800531800; 36237962800; 56714139600 ⓘ sjg@knu.ac.kr; ⓘ ENERGY ⓘ ENERGY ⓘ 0360-5442 1873-6785 323 SCIE ENERGY & FUELS;THERMODYNAMICS ⓘ 2024 9.4 3.2 0 2025-05-07 ⓘ 1 1 Electric vehicle; Lightweighting; Real-world driving test; Simulation; Regenerative braking ⓘ REGENERATIVE BRAKING CONTRIBUTION; EFFICIENCY IMPROVEMENT; EVALUATION METHODOLOGY; EMISSIONS; CO2 ⓘ Electric vehicle; Lightweighting; Real-world driving test; Regenerative braking; Simulation ⓘ Driving conditions; Driving test; Energy; Energy-consumption; Lightweighting; Real-world driving test; Real-world drivings; Road gradients; Simulation; Vehicle weights; battery; depth; electric vehicle; energy efficiency; energy use; friction; simulation ⓘ English 2025 2025-05-15 10.1016/j.energy.2025.135746 ⓘ 바로가기 바로가기 바로가기 바로가기
○ Meeting Abstract ⓘ Lipid Profile Trajectory in Patients With Interstitial Lung Disease: A Matched Control Study ⓘ ⓘ Jang, H.; Jeong, J.; Huh, J.; Kim, K.; Choi, W. ⓘ Inha Univ, Inha Univ Hosp, Coll Med, Incheon, South Korea; Kyungpook Natl Univ, Dept Stat, Kyungpook, South Korea; Chung Ang Univ, Gwangmyeong Hosp, Div Pulm Allergy & Crit Care Med, Gwangmyeong Si, South Korea; Catholic Univ Korea, Div Pulm & Crit Care Med, Dept Internal Med, Incheon, South Korea; Hanyang Univ, Myongji Hosp, Dept Internal Med, Goyang Si, South Korea ⓘ ⓘ ⓘ rose4359@gmail.com; ⓘ AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE ⓘ AM J RESP CRIT CARE ⓘ 1073-449X 1535-4970 211 SCIE CRITICAL CARE MEDICINE;RESPIRATORY SYSTEM ⓘ 2024 19.4 3.2 ⓘ 0 ⓘ ⓘ ⓘ ⓘ English 2025 2025-05-01 ⓘ 바로가기 바로가기
○ ○ Article ⓘ Multi-model integration for dynamic forecasting (MIDF): a framework for wind speed and direction prediction ⓘ Accurate forecasting of wind speed and direction is critical for the efficient integration of wind power into energy systems, ensuring reliable renewable energy production and grid stability. Traditional methods often struggle with capturing nonlinear interdependencies, quantifying uncertainties, and providing reliable long-term predictions, particularly in complex atmospheric conditions. To address these challenges, this study introduces multi-model Integration for dynamic forecasting (MIDF), an ensemble machine learning framework that combines the strengths of DeepAR and temporal fusion transformer (TFT) models through a two-step meta-learning process. MIDF leverages DeepAR's probabilistic forecasting capabilities and TFT's attention mechanisms to enhance accuracy, robustness, and interpretability. Using a custom meteorological dataset spanning January 2010 to May 2023, the model was evaluated against standalone alternatives across multiple metrics, including MSE, RMSE, and R2. MIDF achieved superior performance, with MSE, RMSE, and R2 values of 0.0035, 0.01913, and 0.89 for wind speed, and 0.00052, 0.02507, and 0.86 for wind direction, significantly reducing errors compared to existing methods. These results underscore the potential of ensemble learning in advancing wind forecasting accuracy, enabling more reliable renewable energy management, operational planning, and risk mitigation in meteorological applications. ⓘ Maruthi, Molaka; Kim, Bubryur; Sujeen, Song; An, Jinwoo; Chen, Zengshun ⓘ Kyungpook Natl Univ, Sch Architecture Civil Environm & Energy Engn, 80 Daehak Ro, Daegu 41566, South Korea; Kyungpook Natl Univ, Sch Space Engn Sci, 80 Daehak Ro, Daegu 41566, South Korea; Kyungpook Natl Univ, Dept Robot & Smart Syst Engn, 80 Daehak Ro, Daegu 41566, South Korea; Kyungpook Natl Univ, Dept Safety Convergence, 80 Daehak Ro, Daegu 41566, South Korea; Dept Earth Turbine, 36,Dongdeok Ro 40 Gil, Daegu 41905, South Korea; Univ Texas Rio Grande Valley, Coll Engn & Comp Sci, Dept Civil Engn, Edinburg, TX 78539 USA; Chongqing Univ, Sch Civil Engn, Chongqing 400044, Peoples R China ⓘ ⓘ 59694768200; 57198355299; 59695620900; 56319889200; 55866149500 ⓘ molakamaruthi@gmail.com; brkim@knu.ac.kr; Songsujeen69@gmail.com; jinwoo.an@utrgv.edu; zengshunchen@qq.com; ⓘ ARTIFICIAL INTELLIGENCE REVIEW ⓘ ARTIF INTELL REV ⓘ 0269-2821 1573-7462 58 6 SCIE COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE ⓘ 2024 13.9 3.2 0 2025-05-07 ⓘ 0 0 Ensemble learning; Meta-learning; Wind speed; Wind direction; Multi-model integration for dynamic forecasting; Time series forecasting ⓘ POWER; MODEL; CNN ⓘ Ensemble learning; Meta-learning; Multi-model integration for dynamic forecasting; Time series forecasting; Wind direction; Wind speed ⓘ Weather forecasting; Wind power; Wind power integration; Wind speed; Windmill; Dynamic forecasting; Ensemble learning; Metalearning; Multi-model integration; Multi-model integration for dynamic forecasting; Renewable energies; Time series forecasting; Wind directions; Wind speed; Wind speed and directions; Wind forecasting ⓘ English 2025 2025-03-15 10.1007/s10462-025-11140-x ⓘ 바로가기 바로가기 바로가기 바로가기
○ ○ Article ⓘ Near-Infrared Long-Lived Luminescent Nanoparticle-Based Time-Gated Imaging for Background-Free Detection of Avian Influenza Virus ⓘ Near-infrared (NIR)-to-NIR upconversion nanoparticles (UCNPs) are promising materials for biomedical imaging and sensing applications. However, UCNPs with long lifetimes continue to face the limitation that they are usually accompanied by weak luminescence intensity, resulting in difficulties in achieving high-resolution and sensitive time-gated imaging. To overcome this limitation, we have developed NIR long-lifetime luminescent nanoparticles (NLL NPs) with strong 800 nm emission by adding a photosensitizing shell and with a prolonged lifetime by lowering the activator concentration. NLL NP-based time-gated imaging overcomes the inherent limitations of steady-state imaging by providing higher signal-to-noise ratios and more robust signal intensities. When integrated into a lateral flow immunoassay (LFA) for the detection of avian influenza viruses, NLL NP-based time-gated imaging demonstrates a 32-fold lower limit of detection compared to conventional optimal 800 nm emitting nanoparticles. Furthermore, the high accuracy of the NLL NP-based LFA is confirmed through clinical validations using 65 samples, achieving a sensitivity and specificity of 100% and an area under the curve of 1.000. These results demonstrate the potential of NLL NP-based time-gated imaging as a powerful tool for the highly sensitive and accurate detection of avian influenza viruses in complex clinical samples. ⓘ Han, Jiwoo; Kim, Suyeon; Kang, Dongkyu; Lee, Sun-Hak; Cho, Andrew Y.; Lee, Heesu; Kwon, Jung-Hoon; Shin, Yong; Kim, Young-Pil; Lee, Joonseok ⓘ Hanyang Univ, Res Inst Convergence Basic Sci, Dept Chem, Seoul 04763, South Korea; Konkuk Univ, Coll Vet Med, Avian Dis Lab, Seoul 143701, South Korea; Kyungpook Natl Univ, Coll Vet Med, Lab Vet Microbiol, Daegu 41566, South Korea; Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul 03722, South Korea; Hanyang Univ, Dept Life Sci, Seoul 04763, South Korea ⓘ Lee, Joonseok/AFQ-8078-2022; Lee, Joonseok/E-5695-2013; Kim, Young-Pil/A-5437-2009 ⓘ 59516169800; 55857395100; 57212101460; 57201463694; 57211355010; 58108140200; 55559800200; 59722166200; 56191363500; 56174292800 ⓘ shinyongno1@yonsei.ac.kr; ypilkim@hanyang.ac.kr; joonseoklee@hanyang.ac.kr; ⓘ ACS SENSORS ⓘ ACS SENSORS ⓘ 2379-3694 10 2 SCIE CHEMISTRY, ANALYTICAL;CHEMISTRY, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY ⓘ 2024 9.1 3.2 3.33 2025-05-07 ⓘ 2 2 NIR long-lifetime; upconversionnanoparticles; time-gated imaging; background-freedetection; high signal-to-noise ratio; lateral flowimmunoassay ⓘ UP-CONVERSION ⓘ background-free detection; high signal-to-noise ratio; lateral flow immunoassay; NIR long-lifetime; time-gated imaging; upconversion nanoparticles ⓘ Animals; Birds; Humans; Immunoassay; Influenza A virus; Influenza in Birds; Infrared Rays; Limit of Detection; Nanoparticles; Nanoclay; nanoparticle; Background-free detection; High signal-to-noise ratio; Lateral flow immunoassay; Long lifetime; Luminescent nanoparticle; Near Infrared; Near-infrared; Near-infrared long-lifetime; Time-gated imaging; Upconversion nanoparticles; animal; avian influenza; bird; chemistry; diagnosis; human; immunoassay; Influenza A virus; infrared radiation; isolation and purification; limit of detection; procedures; Nanoparticles ⓘ English 2025 2025-02-15 10.1021/acssensors.4c03202 ⓘ 바로가기 바로가기 바로가기 바로가기
○ ○ Article ⓘ Prolonged adaptation to a robotic prosthesis enhances gait symmetry: A case study in a transtibial amputee ⓘ Purpose: This study evaluates the long-term biomechanical and energy efficiency effects of a high-torque, lightweight robotic ankle-foot prosthesis (RAF Pro) in a transtibial amputee, focusing on its potential to enhance gait symmetry and functionality. Methods: A six-month longitudinal case study was conducted on a 51-year-old male transtibial amputee transitioning from a passive prosthesis to the RAF Pro. Comprehensive gait analyses, including motion capture and force plate assessments, were performed at four intervals: initial fitting, three months, four and a half months, and six months. The participant received continuous, tailored rehabilitation training throughout the study. Results: Over the adaptation period, notable improvements were observed in plantarfiexion during toe-off and in the coordination of hip and knee joint movements, contributing to enhanced gait symmetry. By the six-month mark, the subject achieved near-symmetrical gait mechanics with significantly reduced energy expenditure during walking, approaching the biomechanical efficiency observed in non-amputees. Conclusion: This case study highlights the potential of long-term adaptive rehabilitation combined with advanced robotic prostheses to restore natural, energy-efficient gait mechanics in transtibial amputees. The findings emphasize the importance of a minimum six-month adaptation period for optimizing prosthetic function, offering valuable insights for personalized rehabilitation strategies and future prosthetic development. (c) 2025 The Author(s). Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) ⓘ Kim, Jeongmin; Yi, Hak; Hwang, Donghwan; Jung, Jiuk; Lee, Hyuk Jin; Cho, Jang Ho; Bok, Soo-Kyung; Lee, Yongkoo ⓘ Kyungpook Natl Univ, Dept Mech Engn, 80 Daehak Ro, Daegu 41566, South Korea; Daegu Gyeongbuk Med Innovat Fdn, Med Device Dev Ctr, 80 Cheombok Ro, Daegu 41061, South Korea; Korea Inst Machinery & Mat, Daegu Res Ctr Med Devices & Green Energy, 330 Techno Sunhwan Ro, Dalseong Gun 42994, Daegu, South Korea; Chungnam Natl Univ Hosp, Dept Rehabil Med, 282 Munhwa Ro, Daejeon 35015, South Korea ⓘ ⓘ 58805344500; 59815734600; 57219450749; 59740278000; 59856410300; 7403536244; 55375467400; 57189226732 ⓘ ylee2012@kimm.re.kr; ⓘ ANNALS OF PHYSICAL AND REHABILITATION MEDICINE ⓘ ANN PHYS REHABIL MED ⓘ 1877-0657 1877-0665 68 5 SCIE REHABILITATION ⓘ 2024 4.6 3.2 0 2025-05-07 ⓘ 0 0 Transtibial amputee; Robotic ankle-foot prosthesis; Gait symmetry; Rehabilitation; Adaptation Training ⓘ ENERGY-EXPENDITURE ⓘ Adaptation Training; Gait symmetry; Rehabilitation; Robotic ankle-foot prosthesis; Transtibial amputee ⓘ adaptation; adult; Article; biomechanics; case report; clinical article; energy expenditure; force; gait; hip joint; human; joint angle; knee joint; leg amputee; longitudinal study; male; middle aged; motion capture; rehabilitation care; stride time; torque; walking; walking speed ⓘ English 2025 2025-06 10.1016/j.rehab.2025.101981 ⓘ 바로가기 바로가기 바로가기 바로가기
○ ○ Article ⓘ Surface reaction mechanism and characteristics of 2-dimensional TiO2 and 0-dimensional Ag nanocomposites specialized for H2S gas sensing at room temperature ⓘ In this study, we provide the synthesis of pristine TiO2 nanosheets (NSs) via a simple flux method and their decoration with Ag nanoparticles (NPs) using a hydrothermal method for room-temperature H2S gas sensing. Gas sensing experiments were conducted at 25 degrees C, evaluating the response of the Ag NPs-decorated TiO2 NSs to various gases. Results demonstrated the gas sensor exhibited a superior response to H2S gas compared to other gases, outperforming the pristine TiO2 NSs gas sensor. Additionally, its response to H2S gas surpassed that of the TiO2 NSs gas sensor, highlighting the promising role of Ag decoration for H2S gas detection. Sensing behavior in humid atmosphere was also investigated. The improved H2S gas sensing performance can be attributed to the catalytic effect of Ag, the formation of Ag/TiO2 heterojunctions, and the large surface area of the TiO2 NSs. This study introduces a straightforward approach to enhance the gas sensing capabilities of metal oxide NSs. ⓘ Lee, Un Yup; Kim, Min Young; Lee, Kyu Hyoung; Han, Sol; Lee, Seung Yong; Mirzaei, Ali; Choi, Sun-Woo; Choi, Myung Sik; Jin, Changhyun; Hwang, Jeong Yun ⓘ Yonsei Univ, Dept Mat Sci & Engn, Seoul 03722, South Korea; Shiraz Univ Technol, Dept Mat Sci & Engn, Shiraz 7155713876, Iran; Kangwon Natl Univ, Dept Mat Sci & Engn, Samcheok 25913, South Korea; Kyungpook Natl Univ, Dept Nano & Adv Mat Sci & Engn, Sangju 37224, South Korea ⓘ Choi, Myung-Sik/J-5687-2012; Mirzaei, Ali/J-8849-2019 ⓘ 59013293800; 57221074025; 57209573421; 59539792400; 57436380000; 57196467909; 35106725800; 57190737942; 35177895100; 57215200308 ⓘ ms.choi@knu.ac.kr; z8015026@yonsei.ac.kr; jyhawng@yonsei.ac.kr; ⓘ SENSORS AND ACTUATORS REPORTS ⓘ SENSOR ACTUATOR REP ⓘ 2666-0539 9 ESCI CHEMISTRY, ANALYTICAL;ELECTROCHEMISTRY;INSTRUMENTS & INSTRUMENTATION;NANOSCIENCE & NANOTECHNOLOGY;BIOTECHNOLOGY & APPLIED MICROBIOLOGY ⓘ 2024 7.6 3.2 0 2025-05-07 ⓘ 0 1 H2S gas sensor; TiO2 nanosheets; Ag decoration; Ag/TiO2 heterojunctions; Room temperature ⓘ SENSORS; OXIDE ⓘ Ag decoration; Ag/TiO<sub>2</sub> heterojunctions; H<sub>2</sub>S gas sensor; Room temperature; TiO<sub>2</sub> nanosheets ⓘ Chemical sensors; Gas detectors; Gas sensing electrodes; Gases; Hydrothermal synthesis; II-VI semiconductors; Metal nanoparticles; Nanocomposites; Silver nanoparticles; TiO2 nanoparticles; Titanium dioxide; Ag decoration; Ag/TiO 2; Ag/TiO2 heterojunction; Gas sensing; Gas-sensors; H2S gas sensor; Reaction characteristics; Surface reaction mechanism; TiO 2; TiO2 nanosheet; Nanosheets ⓘ English 2025 2025-06 10.1016/j.snr.2025.100290 ⓘ 바로가기 바로가기 바로가기 바로가기
○ ○ Article ⓘ A randomized non-inferiority trial investigating antibiotic adjustments based on blood culture in acute cholangitis ⓘ Objectives This study evaluated the adequacy of using blood cultures alone for antibiotic therapy in mild-to-moderate acute cholangitis after adequate biliary drainage. Methods A prospective, multi-centre, non-inferiority, randomized trial was conducted from August 2015 to September 2023 across 12 tertiary hospitals in South Korea. Patients were randomly assigned 1:1 to groups. The control group was administered antibiotics based on blood and bile culture results, whereas the experimental group was treated based on blood culture results alone. The primary outcome was the rate of organ failure, assessed by the presence of shock, acute kidney injury, altered mental status, and acute respiratory distress. The secondary outcomes were all-cause mortality, frequency of re-interventions, antibiotic usage duration, and hospital stay. The non-inferiority margin was 10%. Results Patients in the control group (n = 215) and experimental group (n = 213) were analysed. Organ failure occurred in 28 (13.0%) in the control and 27 (12.7%) in the experimental group (difference: -0.350% [95% CI, -6.690% to 5.990%], p > 0.999). Mortality rates were 3.3% in the control (seven patients) and 2.3% in the experimental group (five patients) (-0.908% [-4.033% to 2.216%], p 0.782). The reintervention rates were 31 (14.9%) in the control and 26 (12.2%) in the experimental groups (-2.677% [-9.155% to 3.801%], p 0.504). The antibiotic therapy duration was different (-1.500 days [-2.840 to -0.160], p 0.037) between the control (12.8 +/- 8.0 days) and the experimental groups (11.3 +/- 6.5 days), and the hospital stay was different (-1.900 days [-0.380 to 0.000], p 0.046) between the control (14.1 +/- 11.0 days) and the experimental groups (12.2 +/- 9.0 days). Discussion This study confirms that relying on blood culture results alone for managing mild-to-moderate cholangitis is reasonable and may help reduce the unnecessary use of medical resources. Tae Seung Lee, Clin Microbiol Infect 2025;31:987 (c) 2025 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. ⓘ Lee, Tae Seung; Choi, Jin Ho; Lee, Jae Min; Jeon, Hankyu; Paik, Woo Hyun; Cho, Kwang Bum; Lee, Yoon Suk; Han, Joung-Ho; Joo, Jong Seok; Jung, Min Kyu; Lee, Jonghyun; Ahn, Dong-Won; Park, Jin Myung; Kim, Jaihwan; Lee, Jong-chan; Cho, Eun Ae; Lee, Sang Hyub ⓘ Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med, Seoul, South Korea; Gyeongsang Natl Univ, Changwon Hosp, Dept Internal Med, Coll Med, Chang Won, South Korea; Keimyung Univ, Dept Internal Med, Sch Med, Daegu, South Korea; Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Coll Med, Goyang, South Korea; Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Gastroenterol, Coll Med, Cheongju, South Korea; Chungnam Natl Univ, Chungnam Natl Univ Hosp, Dept Gastroenterol, Sch Med, Daejeon, South Korea; Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea; Pusan Natl Univ Hosp, Biomed Res Inst, Div Gastroenterol, Busan, South Korea; Pusan Natl Univ, Coll Med, Dept Internal Med, Yangsan, South Korea; Seoul Natl Univ, Seoul Metropolitan Govt, Dept Internal Med, Coll Med,Boramae Med Ctr, Seoul, South Korea; Kangwon Natl Univ, Dept Internal Med, Sch Med, Chunchon, South Korea; Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; Chonnam Natl Univ, Dept Internal Med, Med Sch, Gwangju, South Korea ⓘ Paik, Woo/B-9003-2016; Lee, Yoon Suk/D-1827-2019; Jong Seok, Joo/GZA-7315-2022; LEE, Yoon-Suk/D-1827-2019 ⓘ 57220188774; 57202894976; 56557482500; 57203888256; 35822559900; 7403956834; 57219432560; 56222314400; 57188822486; 56783168100; 58294454600; 14022272100; 57205232842; 35310739500; 47561690800; 57225705236; 59054742300 ⓘ gidoctor@snu.ac.kr; ⓘ CLINICAL MICROBIOLOGY AND INFECTION ⓘ CLIN MICROBIOL INFEC ⓘ 1198-743X 1469-0691 31 6 SCIE INFECTIOUS DISEASES;MICROBIOLOGY ⓘ 2024 8.5 3.3 6.24 2025-05-07 ⓘ 1 1 Acute cholangitis; Antibiotics; Bile culture; Organ failure; Blood culture; Multidrug-resistant organisms; Extended-spectrum beta-lactamase ⓘ COMMON BILE-DUCT; MICROBIOLOGY ⓘ Acute cholangitis; Antibiotics; Bile culture; Blood culture; Extended-spectrum beta-lactamase; Multidrug-resistant organisms; Organ failure ⓘ Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Blood Culture; Cholangitis; Female; Humans; Male; Middle Aged; Prospective Studies; Republic of Korea; Treatment Outcome; carbapenem; ceftriaxone; metronidazole; quinolone derivative; third generation cephalosporin; antiinfective agent; acute disease; acute kidney failure; aged; all cause mortality; altered state of consciousness; antibiotic therapy; Article; biliary tract drainage; blood culture; carbapenem resistance; cholangitis; controlled study; drug dose escalation; endoscopic retrograde cholangiopancreatography; Escherichia coli; female; fluoroquinolone resistance; hospitalization; human; major clinical study; male; mortality rate; multicenter study; non-inferiority trial; outcome assessment; practice guideline; prospective study; randomized controlled trial; respiratory distress; tertiary care center; treatment duration; acute disease; cholangitis; clinical trial; drug therapy; microbiology; middle aged; mortality; South Korea; treatment outcome; very elderly ⓘ English 2025 2025-06 10.1016/j.cmi.2024.12.039 ⓘ 바로가기 바로가기 바로가기 바로가기
○ ○ Article ⓘ Effects of blood pressure lowering in patients treated with intravenous thrombolysis before endovascular thrombectomy ⓘ Background: The effects of blood pressure (BP) lowering in patients treated with intravenous tissue plasminogen activator (IV tPA) before endovascular thrombectomy (EVT) are unclear. Aims: This study aims to investigate whether intensive and conventional BP management affects outcomes differently, depending on IV tPA administration before EVT. Methods: In this subgroup analysis of the Outcome in Patients Treated with Intra-Arterial Thrombectomy-Optimal Blood Pressure Control (OPTIMAL-BP; ClinicalTrials.gov Identifier: NCT04205305) trial, patients were divided into groups based on IV tPA use before EVT. Clinical outcomes of intensive (systolic BP target < 140 mm Hg) or conventional BP management (systolic BP target 140-180 mm Hg) were compared among groups. The primary efficacy outcome was a favorable outcome at 3 months (modified Rankin Scale score of 0-2). Primary safety outcomes included symptomatic intracerebral hemorrhage (sICH) within 36 h and stroke-related death within 3 months. Results: Among the 302 patients, the IV tPA group included 98 (32.5%) and the non-IV tPA group comprised 204 subjects (67.5%). In the IV tPA group, intensive BP management significantly lowered the favorable outcome rate (intensive, 27.3% vs. conventional, 51.9%; adjusted odds ratio [aOR], 0.36; 95% confidence interval [CI], 0.13-0.93; p = 0.04). In the non-IV tPA group, the risk difference rate of favorable outcome was not significantly different between intensive and conventional BP management (44.1% vs. 55.9%; aOR, 0.62; 95% CI, 0.31-1.22; p = 0.17). Notably, the proportion of malignant cerebral edema within 36 h in the IV tPA group was significantly higher in the intensive management group (18.2%) than in the conventional management group (1.9%; aOR, 10.72; 95% CI, 1.24-92.29; p = 0.03). sICH and mortality rates were not significantly different between intensive and conventional BP management in either study groups. Conclusions: Intensive BP management worsens 3-month functional outcomes after successful EVT without reducing sICH among patients who received IV tPA before EVT, indicating that BP lowering in this population should be cautious. ⓘ Yun, Jaeseob; Kim, Kwang Hyun; Jung, Jae Wook; Kim, Young Dae; Heo, Joonnyung; Lee, Hyungwoo; Choi, Jin Kyo; Lim, In Hwan; Hong, Soon-Ho; Kim, Byung Moon; Kim, Dong Joon; Shin, Na Young; Cho, Bang-Hoon; Ahn, Seong Hwan; Park, Hyungjong; Sohn, Sung-Il; Hong, Jeong-Ho; Song, Tae-Jin; Chang, Yoonkyung; Kim, Gyu Sik; Seo, Kwon-Duk; Lee, Kijeong; Chang, Jun Young; Seo, Jung Hwa; Lee, Sukyoon; Baek, Jang-Hyun; Cho, Han-Jin; Shin, Dong Hoon; Kim, Jinkwon; Yoo, Joonsang; Baik, Minyoul; Lee, Kyung-Yul; Jung, Yo Han; Hwang, Yang-Ha; Kim, Chi Kyung; Kim, Jae Guk; Lee, Chan Joo; Park, Sungha; Jeon, Soyoung; Lee, Hye Sun; Kwon, Sun U.; Lee, Il Hyung; Bang, Oh Young; Heo, Ji Hoe; Nam, Hyo Suk; OPTIMAL-BP Trial Investigators ⓘ Yonsei Univ, Coll Med, Dept Neurol, Seoul 03722, South Korea; Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea; Korea Univ, Anam Hosp, Dept Neurol, Seoul, South Korea; Coll Med, Seoul, South Korea; Chosun Univ, Sch Med, Dept Neurol, Gwangju, South Korea; Keimyung Univ, Brain Res Inst, Dept Neurol, Sch Med, Daegu, South Korea; Ewha Womans Univ, Seoul Hosp, Coll Med, Dept Neurol, Seoul, South Korea; Ewha Womans Univ, Coll Med, Mokdong Hosp, Dept Neurol, Seoul, South Korea; Natl Hlth Insurance Serv Ilsan Hosp, Goyang, South Korea; Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea; Inje Univ, Coll Med, Busan Paik Hosp, Dept Neurol, Pusan, South Korea; Pusan Natl Univ, Sch Med, Dept Neurol, Pusan, South Korea; Gachon Univ, Gil Med Ctr, Dept Neurol, Incheon, South Korea; Yonsei Univ, Yongin Severance Hosp, Dept Neurol, Coll Med, Yongin, South Korea; Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea; Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Neurol, Daegu, South Korea; Korea Univ, Guro Hosp, Dept Neurol, Seoul, South Korea; Eulji Univ, Daejeon Eulji Med Ctr, Sch Med, Daejeon, South Korea; Yonsei Univ, Coll Med, Severance Hosp, Coll Med, Seoul, South Korea; Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea; Yonsei Univ, Coll Med, Dept Res Affairs, Biostat Collaborat Unit, Seoul, South Korea; Kyung Hee Univ Hosp Gangdong, Dept Neurol, Seoul, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea ⓘ Lee, Hye/J-2154-2015; Lee, Kyung-Yul/KVZ-0950-2024; Kim, Chi/AAR-9819-2020; Hong, Jeong-Ho/T-8099-2018; Yun, Jaeseob/LOS-5991-2024; Seo, Jung/N-2344-2017; Kim, Jinkwon/AAR-6729-2021; Heo, JoonNyung/ABI-5389-2020; Lee, Il-Hyung/E-9712-2011; Park, Hyungjong/AAI-5361-2020; kim, deog young/Q-8498-2019 ⓘ 58905434900; 57209600032; 57217003257; 57293047300; 57219861395; 57209973874; 57215910153; 57214234925; 58312729300; 57225664486; 57965484900; 56363572300; 55171752400; 57200401172; 57199865406; 36479287000; 55931654800; 55507164200; 56525550900; 57204440618; 57219304565; 56101426700; 56346807100; 55471870500; 57217310224; 56066538700; 57211361916; 57222389564; 37090736900; 55261162200; 57197951986; 57306378900; 57217582769; 7402311308; 56701057800; 56720623400; 57226133622; 8556278400; 57223622373; 57208650357; 7402624264; 57394223800; 7006620221; 34869576000; 58719143100 ⓘ hsnam@yuhs.ac; ⓘ INTERNATIONAL JOURNAL OF STROKE ⓘ INT J STROKE ⓘ 1747-4930 1747-4949 20 6 SCIE CLINICAL NEUROLOGY;PERIPHERAL VASCULAR DISEASE ⓘ 2024 8.7 3.3 0 2025-05-07 ⓘ 0 0 Ischemic stroke; thrombectomy; blood pressure; tissue plasminogen activator ⓘ ACUTE ISCHEMIC-STROKE; PLASMINOGEN-ACTIVATOR; THERAPY; BRAIN; NEUROTOXICITY; GUIDELINES; MANAGEMENT ⓘ blood pressure; Ischemic stroke; thrombectomy; tissue plasminogen activator ⓘ ⓘ English 2025 2025-07 10.1177/17474930251315630 ⓘ 바로가기 바로가기 바로가기 바로가기
○ ○ Article ⓘ Intensive blood pressure lowering in acute stroke with intracranial stenosis post-thrombectomy: A secondary analysis of the OPTIMAL-BP trial ⓘ Background: Intensive blood pressure (BP) management within 24 h after successful reperfusion following endovascular thrombectomy (EVT) is associated with worse functional outcomes than conventional BP management in Asian randomized controlled trials. Given the high prevalence of intracranial atherosclerotic stenosis (ICAS) in Asia, ICAS may influence these outcomes. Aims: We aimed to assess whether ICAS affects the outcomes of intensive BP management after successful EVT. Methods: We conducted a secondary analysis of the Outcome in Patients Treated With Intra-Arterial Thrombectomy-Optimal Blood Pressure Control trial, which enrolled participants from June 2020 to November 2022. Patients with anterior circulation large vessel occlusion (LVO) were stratified into ICAS-related and embolic LVO groups. Clinical outcomes for intensive (target systolic BP < 140 mm Hg) and conventional BP management (target systolic BP = 140-180 mm Hg) were analyzed in each group. The primary outcome was a favorable outcome, defined as a modified Rankin Scale score of 0 to 2 at 3 months. Safety outcomes included symptomatic intracerebral hemorrhage within 36 h and stroke-related death within 3 months. Results: Among 192 patients, 59 were in the ICAS-related LVO group, and 133 were in the embolic LVO group. In the ICAS-related LVO group, the rate of achieving a favorable outcome at 3 months was 37.5% with intensive BP management and 55.6% with conventional management (adjusted odds ratio (OR) = 0.49 (95% confidence interval (CI) = 0.14 to 1.75); P = 0.27). In the embolic LVO group, these rates were 29.9% and 42.4%, respectively (adjusted OR = 0.64 (95% CI = 0.28 to 1.45); P = 0.29). No significant interaction was found (P for interaction = 0.68). In addition, the ICAS-related LVO group receiving intensive BP management had lower rates of successful reperfusion at 24 h compared to conventional management (67.7% vs. 91.7%; P = 0.03), while no significant difference was found in the embolic LVO group. A significant interaction effect on successful reperfusion at 24 h was observed between ICAS-related and embolic LVO groups (P for interaction = 0.04). No significant differences in safety outcomes were observed between intensive BP management and conventional management within both ICAS-related LVO and embolic LVO groups. Conclusions: ICAS did not significantly affect outcomes of intensive BP management within 24 h after successful EVT. After successful reperfusion by EVT, intensive BP management should be avoided regardless of ICAS presence. Data access statement: The data that support the findings of this study are available from the corresponding author upon reasonable request. ⓘ Kim, Kwang Hyun; Yun, Jaeseob; Jung, Jae Wook; Kim, Young Dae; Heo, Joonnyung; Lee, Hyungwoo; Choi, Jin Kyo; Lee, Il Hyung; Lim, In Hwan; Hong, Soon-Ho; Baik, Minyoul; Kim, Byung Moon; Kim, Dong Joon; Shin, Na-Young; Cho, Bang-Hoon; Ahn, Seong Hwan; Park, Hyungjong; Sohn, Sung-Il; Hong, Jeong-Ho; Song, Tae-Jin; Chang, Yoonkyung; Kim, Gyu Sik; Seo, Kwon-Duk; Lee, Kijeong; Chang, Jun Young; Seo, Jung Hwa; Lee, Sukyoon; Baek, Jang-Hyun; Cho, Han-Jin; Shin, Dong Hoon; Kim, Jinkwon; Yoo, Joonsang; Lee, Kyung-Yul; Jung, Yo Han; Hwang, Yang-Ha; Kim, Chi Kyung; Kim, Jae Guk; Lee, Chan Joo; Park, Sungha; Lee, Hye Sun; Kwon, Sun U.; Bang, Oh Young; Heo, Ji Hoe; Nam, Hyo Suk ⓘ Yonsei Univ, Coll Med, Dept Neurol, 50-1 Yonsei Ro, Seoul 03722, South Korea; Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea; Korea Univ, Anam Hosp, Coll Med, Dept Neurol, Seoul, South Korea; Chosun Univ, Sch Med, Dept Neurol, Gwangju, South Korea; Keimyung Univ, Brain Res Inst, Sch Med, Dept Neurol, Daegu, South Korea; Ewha Womans Univ, Seoul Hosp, Coll Med, Dept Neurol, Seoul, South Korea; Ewha Womans Univ, Mokdong Hosp, Coll Med, Dept Neurol, Seoul, South Korea; Natl Hlth Insurance Serv Ilsan Hosp, Dept Neurol, Goyang, South Korea; Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea; Dong A Univ Hosp, Dept Neurol, Busan, South Korea; Inje Univ, Busan Paik Hosp, Coll Med, Dept Neurol, Busan, South Korea; Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Dept Neurol, Seoul, South Korea; Pusan Natl Univ, Sch Med, Dept Neurol, Busan, South Korea; Gachon Univ, Gil Med Ctr, Dept Neurol, Incheon, South Korea; Yonsei Univ, Yongin Severance Hosp, Coll Med, Dept Neurol, Yongin, South Korea; Yonsei Univ, Gangnam Severance Hosp, Dept Neurol, Coll Med, Seoul, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Daegu, South Korea; Korea Univ, Guro Hosp, Coll Med, Guro Hosp, Seoul, South Korea; Eulji Univ, Daejeon Eulji Med Ctr, Sch Med, Dept Neuropsychiat, Daejeon, South Korea; Yonsei Univ, Severance Hosp, Dept Internal Med, Div Cardiol,Dept Internal Med, Seoul, South Korea; Yonsei Univ, Coll Med, Integrat Res Ctr Cerebrovascular & Cardiovasc Dis, Seoul, South Korea; Yonsei Univ, Coll Med, Dept Res Affairs, Biostat Collaborat Unit, Seoul, South Korea; Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Neurol, Seoul, South Korea ⓘ ; Kim, Chi/AAR-9819-2020; Kim, Jinkwon/AAR-6729-2021; Seo, Jung/N-2344-2017; Yun, Jaeseob/LOS-5991-2024; Heo, JoonNyung/ABI-5389-2020; kim, deog young/Q-8498-2019; Park, Hyungjong/AAI-5361-2020; Kim, Jinkwon/N-1878-2018; Lee, Kyung-Yul/KVZ-0950-2024; Lee, Il-Hyung/E-9712-2011; Lee, HS/AAD-6757-2019; Lee, Eun-Hye/KDN-5679-2024; Hong, Jeong-Ho/T-8099-2018 ⓘ 57209600032; 58905434900; 57217003257; 57293047300; 57219861395; 57209973874; 57215910153; 57394223800; 57214234925; 58312729300; 57197951986; 57225664486; 57965484900; 56363572300; 55171752400; 57200401172; 57199865406; 36479287000; 55931654800; 55507164200; 56525550900; 57204440618; 57219304565; 56101426700; 56346807100; 55471870500; 57217310224; 56066538700; 57211361916; 57222389564; 37090736900; 55261162200; 57306378900; 57217582769; 7402311308; 56701057800; 56720623400; 57226133622; 8556278400; 57208650357; 7402624264; 7006620221; 34869576000; 58719143100 ⓘ hsnam@yuhs.ac; ⓘ INTERNATIONAL JOURNAL OF STROKE ⓘ INT J STROKE ⓘ 1747-4930 1747-4949 20 3 SCIE CLINICAL NEUROLOGY;PERIPHERAL VASCULAR DISEASE ⓘ 2024 8.7 3.3 0 2025-05-07 ⓘ 0 0 Intracranial stenosis; thrombectomy; blood pressure ⓘ ACUTE ISCHEMIC-STROKE; ENDOVASCULAR THERAPY; MANAGEMENT; TARGET ⓘ blood pressure; Intracranial stenosis; thrombectomy ⓘ Aged; Antihypertensive Agents; Blood Pressure; Endovascular Procedures; Female; Humans; Intracranial Arteriosclerosis; Ischemic Stroke; Male; Middle Aged; Stroke; Thrombectomy; Treatment Outcome; antihypertensive agent; aged; angioplasty; aortic stenosis; artery reocclusion; Article; blood clot lysis; blood pressure; blood pressure measurement; blood pressure regulation; brain edema; cerebral atherosclerosis; cerebrovascular accident; clinical outcome; computer assisted tomography; controlled study; coronary reperfusion; diagnostic accuracy; digital subtraction angiography; female; follow up; hospitalization; human; intensive care; internal carotid artery; internal carotid artery stenosis; major clinical study; male; massive intracerebral hemorrhage; middle cerebral artery; multicenter study; National Institutes of Health Stroke Scale; nuclear magnetic resonance imaging; outcome assessment; percutaneous thrombectomy; prevalence; prospective study; quality of life; randomized controlled trial; Rankin scale; secondary analysis; subarachnoid hemorrhage; systolic blood pressure; thrombectomy; blood pressure; cerebrovascular accident; complication; drug effect; endovascular surgery; ischemic stroke; middle aged; physiology; procedures; surgery; thrombectomy; treatment outcome ⓘ English 2025 2025-03 10.1177/17474930241305315 ⓘ 바로가기 바로가기 바로가기 바로가기
페이지 이동: